The ASXL–BAP1 axis: new factors in myelopoiesis, cancer and epigenetics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2012288.pdf
Reference46 articles.
1. Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 2012; 337: 1541–1546.
2. Abdel-Wahab O, Adli M, Lafave LM, Gao J, Hricik T, Shih AH et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 2012; 22: 180–193.
3. Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A . The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 2009; 284: 34179–34188.
4. Sowa ME, Bennett EJ, Gygi SP, Harper JW . Defining the human deubiquitinating enzyme interaction landscape. Cell 2009; 138: 389–403.
5. Sinclair DA, Milne TA, Hodgson JW, Shellard J, Salinas CA, Kyba M et al. The additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. Development 1998; 125: 1207–1216.
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1;Frontiers in Immunology;2024-03-11
2. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets;Translational Lung Cancer Research;2023-04
3. Histone H2A deubiquitinases in the transcriptional programs of development and hematopoiesis: a consolidated analysis;The International Journal of Biochemistry & Cell Biology;2023-04
4. A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review;Translational Pediatrics;2023-01
5. FOXK2 transcription factor and its roles in tumorigenesis (Review);Oncology Letters;2022-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3